597 related articles for article (PubMed ID: 187324)
1. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
Fidler IJ; Kataoka T; Hanna MG
Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
[TBL] [Abstract][Full Text] [Related]
2. Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells.
Bucana C; Hoyer LC; Hobbs B; Breesman S; McDaniel M; Hanna MG
Cancer Res; 1976 Dec; 36(12):4444-58. PubMed ID: 187323
[TBL] [Abstract][Full Text] [Related]
3. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
Germain RN; Williams RM; Benacerraf B
J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of active specific immunotherapy and chemotherapy in guinea pigs with disseminated cancer.
Key ME; Brandhorst JS; Hanna MG
J Immunol; 1983 Jun; 130(6):2987-92. PubMed ID: 6304194
[TBL] [Abstract][Full Text] [Related]
5. Complete regression of a guinea pig hepatocarcinoma by immunotherapy with "tumor-immune" RNA or antibody to fibrin fragment E.
Schlager SI; Dray S
Isr J Med Sci; 1976; 12(4-5):344-59. PubMed ID: 181352
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.
Hanna MG; Peters LC
Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374
[TBL] [Abstract][Full Text] [Related]
7. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
[No Abstract] [Full Text] [Related]
8. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
Key ME; Hanna MG
J Natl Cancer Inst; 1981 Oct; 67(4):853-61. PubMed ID: 6944552
[TBL] [Abstract][Full Text] [Related]
9. ADCC mediated by non-adherent mononuclear and polymorphonuclear cells of the guinea-pig.
Hopkins SJ; Dale MM
Immunology; 1980 Aug; 40(4):513-9. PubMed ID: 7429541
[TBL] [Abstract][Full Text] [Related]
10. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
Minden P; Mathews HL
Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
[TBL] [Abstract][Full Text] [Related]
11. Multiple in vitro mechanisms of tumor cytotoxicity demonstrated in the line-1 guinea pig hepatoma model.
Osteen RT; Piessens WF; David JR; Churchill WH
J Natl Cancer Inst; 1975 Oct; 55(4):873-8. PubMed ID: 52720
[TBL] [Abstract][Full Text] [Related]
12. Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
de Jong WH; van de Plas MM; Steerenberg PA; Kruizinga W; Ruitenberg EJ
J Immunol; 1985 Mar; 134(3):2032-40. PubMed ID: 2578526
[TBL] [Abstract][Full Text] [Related]
13. Suppression of growth of guinea pig line-10 hepatocarcinoma. II. Effect of passive transfer of xenogeneic and syngeneic antibodies and normal lymphoid cells.
Minden P; Brunda MJ; Ferguson HR
J Immunol; 1978 Nov; 121(5):1933-8. PubMed ID: 712072
[TBL] [Abstract][Full Text] [Related]
14. Transfer of tumor-specific delayed hypersensitivity in vitro to normal guinea pig peritoneal exudate cells using RNA extracts from sensitized lymphoid tissues.
Paque RE; Meltzer MS; Zbar B; Rapp HJ; Dray S
Cancer Res; 1973 Dec; 33(12):3165-71. PubMed ID: 4357351
[No Abstract] [Full Text] [Related]
15. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
[No Abstract] [Full Text] [Related]
16. Complete and apparently specif local tumor regression using syngeneic or xenogeneic "tumor-immune" RNA extracts.
Schlager SI; Paque RE; Dray S
Cancer Res; 1975 Aug; 35(8):1907-14. PubMed ID: 167938
[TBL] [Abstract][Full Text] [Related]
17. Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.
Piessens WF; Churchill WH; David
J Immunol; 1975 Jan; 114(1 Pt 2):293-9. PubMed ID: 163856
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific immune responsiveness of the tumor-bearing host.
Burk MW; Yu S; McKhann CF
Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
[TBL] [Abstract][Full Text] [Related]
19. Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases.
Yarkoni E; Ashley MP; Zbar B; Sugimoto T; Rapp HJ
Cancer Res; 1982 Jul; 42(7):2544-6. PubMed ID: 7083146
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity between Bacillus Calmette-Guérin and Rous Virus-induced sarcoma detected in rats by tube leukocyte adherence inhibition assay.
Holán V; Chutná J; Hasek M
Cancer Res; 1979 Feb; 39(2 Pt 2):593-6. PubMed ID: 216490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
